Assessment of Spillover of Antimicrobial Resistance to Untreated Children 7-12 Years Old After Mass Drug Administration of Azithromycin for Child Survival in Niger: A Secondary Analysis of the MORDOR Cluster-Randomized Trial.

Saved in:
Bibliographic Details
Title: Assessment of Spillover of Antimicrobial Resistance to Untreated Children 7-12 Years Old After Mass Drug Administration of Azithromycin for Child Survival in Niger: A Secondary Analysis of the MORDOR Cluster-Randomized Trial.
Authors: Peterson B; Francis I. Proctor Foundation, University of California, San Francisco, California, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA., Arzika AM; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Amza A; Programme Nationale de Santé Oculaire, Niamey, Niger., Maliki R; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Karamba AM; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Moussa M; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Kemago M; Centre de Recherche et Interventions en Santé Publique, Birni N'Gaoure, Niger., Liu Z; Francis I. Proctor Foundation, University of California, San Francisco, California, USA., Houpt E; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, USA., Liu J; School of Public Health, Qingdao University, Qingdao, China., Pholwat S; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, Virginia, USA., Doan T; Francis I. Proctor Foundation, University of California, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, California, USA., Porco TC; Francis I. Proctor Foundation, University of California, San Francisco, California, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, California, USA.; Institute for Global Health Sciences, University of California, San Francisco, California, USA., Keenan JD; Francis I. Proctor Foundation, University of California, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, California, USA., Lietman TM; Francis I. Proctor Foundation, University of California, San Francisco, California, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, California, USA.; Institute for Global Health Sciences, University of California, San Francisco, California, USA., O'Brien KS; Francis I. Proctor Foundation, University of California, San Francisco, California, USA.; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.; Department of Ophthalmology, University of California, San Francisco, California, USA.; Institute for Global Health Sciences, University of California, San Francisco, California, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Nov 22; Vol. 79 (5), pp. 1136-1143.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciae267